Skip to main content
. 2024 Jan 17;16(1):120. doi: 10.3390/pharmaceutics16010120

Table 3.

Continuous and pulsed disease-modifying therapies for relapsing multiple sclerosis.

Disease-modifying therapies for relapsing multiple sclerosis.
Continuous therapy:

  • Interferon-beta (IFNβ);

  • Glatiramer acetate (GA);

  • Teriflunomide (TF);

  • Dimethyl fumarate (DMF);

  • Sphingosine-1-phosphate receptor modulators (Fingolimod (FG), Siponimod (SP), and Ozanimod (OZ));

  • Natalizumab (Nat);

  • B cell depletion therapy (rituximab, ocrelizumab, ofatumumab).

Pulsed therapy:

  • Alemtuzumab;

  • Cladribine.